Introduction
============

Delirium, as defined by the *Diagnostic and Statistic Manual 5th edition*, is characterized as the fluctuation of changes in the level of consciousness affecting attention, awareness, and cognition of a patient.[@b1-por-9-011] This fluctuation finally results in development of delirium. The onset of delirium ranges from a few minutes since discontinuation of sedation to a few days after the patient has been admitted to the intensive care unit (ICU).

Moreover, early recognition of delirium by all staff who deal with the patient has been demonstrated to be of utmost importance for patients' in-hospital progress, as shown in Eden and Foreman's case study.[@b26-por-9-011] It is widely documented that a lack of recognition and ineffective communication between health professionals play a significant role toward delirium in ICU patients.[@b2-por-9-011]--[@b4-por-9-011] The main purpose of this study was to focus on this particular subject in cardiac surgery patients and shed light on the process of early identification of the perioperative predictors which would predispose patients to delirium. We also focused on the early recognition of the development of delirium in ICU patients, and our purpose was to illustrate those specific perioperative characteristics that lead to delirium and evaluate the incidence of delirium in cardiac surgery ICU (CICU).

Patients and methods
====================

Study design
------------

The patients included in the study were any elective and non-elective cases who underwent open-heart surgical operations with total cardiopulmonary bypass (CPB).

Three hundred and twenty-seven postoperative cardiac patients with CPB were screened since admission to CICU, and a total of 179 patients were enrolled in the study, which was performed from May until December 2015.

Exclusion criteria were inadequate knowledge of Greek language, hearing or speech impairment, central nervous system cognitive or mental dysfunction prior to operation, drug or alcohol abuse, age \<18 years, and any patients resuscitated from respiratory or cardiac arrest.

Data collection and delirium screening
--------------------------------------

The patients were screened for delirium by using the diagnostic tool of Confusion Assessment Method,[@b5-por-9-011],[@b6-por-9-011] for ICU (CAM-ICU). A short questionnaire on sociodemographics and clinical patient characteristics was used for data collection purposes. Patients' medical files were also reviewed, in order to achieve a more analytical view of their medical condition during the study period.

The institutional protocols for anesthesia and ICU sedation were performed with no specific adjustments for the participants in the study. Etomidate and propofol were used for induction in general anesthesia. Sevoflurane was used for maintenance of sedation intraoperatively and, in terms of analgesia, fentalyl was also administered during the operation. ICU sedation was maintained with propofol. Morphine and paracetamol were prescribed for pain relief. All patients were weaned off sedation and extubated once they became cardiovascularly and respiratorily stable with acid/base balance within a normal range.

Delirium assessment was carried out by 2 of the researchers and took place during the 1st and 2nd postoperative day. The assessment was conducted twice in every shift, in order to record and document any alterations or fluctuations in the mental state of the patients.

First, regarding level of sedation, an assessment took place using the diagnostic tool Richmond Assessment Sedation Scale (RASS score).[@b7-por-9-011] This is a diagnostic tool enabling health professionals to assess the level of sedation or agitation in a patient by the bedside after the infusion of sedative drugs was discontinued.

The patients would have a positive score (anything below --3) and would be defined as comatose if they responded to painful/physical stimulations but would not open their eyes (RASS score −4). If they did not respond to physical/verbal stimuli, they were characterized as having a RASS score equal to −5.

Should the patient present with a negative score (\>−3 up to +4), they could then be screened for delirium with the diagnostic tool of CAM-ICU.

The CAM-ICU form was used in its Greek validated form, and consent for its clinical use was obtained by the authors.[@b6-por-9-011]

The CAM aims to document 4 specific traits of delirium: 1) acute alterations in mental status within a certain period of time, 2) inability of the patient to focus attention, 3) altered level of consciousness, and 4) disorganized structure of thinking. Should the patient present features either of 1) and 2) or 3) and 4), the delirium assessment score would then be defined as positive.

In other words, a patient would be defined as delirious if they responded to verbal stimuli by opening their eyes (having a RASS score ranging from --3 up to +4, which mirrors the level of consciousness) and also presenting (on top of that) with a positive CAM-ICU score.

Delirium was prevented with early mobilization of patients and chest physiotherapy as well as breathing exercises twice a day. In case of delirium onset, nursing interventions were performed in order to alleviate the effects of this condition and haloperidol was also prescribed, titrated to the lowest effective dose as recommended by the American Psychiatric Association.[@b8-por-9-011]

Statistical analysis
--------------------

Categorical and continuous variables are presented as absolute (n) and relative (%) frequencies and mean (standard deviation) or median (range), respectively. The normality assumption was evaluated using the Kolmogorov--Smirnov criterion (*p*\>0.05 for all variables), histograms, and normal probability plots. Bivariate analyses were conducted and included Pearson's χ^2^ test and χ^2^ test for trend to determine associations between categorical variables and Student's *t*-test, analysis of variance, Mann--Whitney test and Kruskal--Wallis test to investigate group differences within continuous variables. Correlation between continuous variables was assessed with Pearson's correlation coefficient, while Spear-man's correlation coefficient was used to investigate the relationship between a continuous and a categorical variable.

Also, multivariate linear and logistic regressions were performed; the results of the linear regressions are presented by using the coefficients' β, the 95% confidence intervals, and the corresponding *p*-values, while the results of the logistic regressions are presented by using the odds ratios, the 95% confidence intervals, and the corresponding *p*-values.

A 2-sided *p*-value of 0.05 was considered statistically significant. The Statistical Package for Social Sciences (IBM Corporation, Armonk, NY, USA) program, version 20.0, was used for statistical analysis.

Ethics
------

The data collection was conducted after permission was issued by the Scientific Board of "Evangelismos" General Hospital prior to the start of the study.

The participants of the study gave their written informed consent preoperatively to be included in the study, so that they would be assessed for delirium in ICU. The investigation was carried out in accordance with the ethical standards of the responsible institutional committee for human experimentation and following the tenets of the Helsinki Declaration of 1975, as revised in 2013. Precautionary measures were taken in order to protect the privacy of the patients and the confidentiality of their personal data, in order to use the minimum amount of information necessitated throughout the study.

Results
=======

Sociodemographic and perioperative data and significant biomarker findings
--------------------------------------------------------------------------

The mean age of patients in this study was 63.3 years, and the majority of them were males (72.1%). Approximately half of the patients underwent exclusively coronary artery bypass grafting (CABG) (52.5%), and nearly a quarter of all patients underwent aortic (AVR) or mitral valve replacement (MVR) (25.1%). In [Table 1](#t1-por-9-011){ref-type="table"}, we present a summary of the sociodemographic, clinical, and perioperative patients' characteristics. The mean ICU and in-hospital length of stay (LOS) were 1.6 and 7.4 days, respectively. In addition, 21 patients (11.7%) were transferred to the high-dependency unit (HDU) after ICU discharge as they were not completely safe to be transferred to the ward yet.

Thirteen out of 179 patients (7.3%) were given blood transfusion, and we also recorded a mean sedation time of 7.2 hours and a mean time of intubation at 10.7 hours. As our unit has a form of cardiac surgery recovery department, we also measured the mean time of ICU LOS in hours (35.1 hours).

Delirium was recorded in 20 out of 179 patients in this study ([Table 2](#t2-por-9-011){ref-type="table"}). The 2-day incidence of delirium in ICU was 11.2% (n=20/179).

We conducted bivariate associations between demographic, perioperative, and patients' data and the outcome of delirium.

In [Table 3](#t3-por-9-011){ref-type="table"}, looking into the types of surgical operation, delirium was recorded more frequently in CABG cases (6 out of 20, *p*=0.032) and AVR + MVR (± CABG) cases (10 out of 20, *p*\<0.001). An elevated EuroSCORE II (mean 6.3) was more significantly correlated with delirium (*p*=0.001).

Looking into patient-related outcomes in [Table 4](#t4-por-9-011){ref-type="table"}, we noticed the following findings: mean and median time of ICU LOS (days) for patients with delirium were higher compared to mean and median time in patients with no delirium (*p*\<0.001). Mean and median time of in-hospital LOS (days) for patients with delirium were higher compared to mean and median time of patients with no delirium (*p*=0.039).

Mean and median time of ICU LOS (h) for patients with delirium was higher compared to mean time of patients with no delirium (*p*\<0.001).

Median and mean time of LOS with endotracheal tube for patients with delirium were both higher compared to median and mean time of patients with no delirium (*p*=0.001).

In [Table 5](#t5-por-9-011){ref-type="table"}, the results showed that patients who developed delirium postoperatively were significantly older (mean age: 69 vs 62 years, *p*=0.020). They also had higher body mass index (29.2 vs 27.9, *p*=0.226), but without statistical significance.

Regarding the operation procedure data, total CPB and total ischemia time during CPB were both prolonged in patients with delirium (140.2 vs 118.8 minutes, *p*-value =0.113 and 90.1 vs 75.8 minutes, *p*-value =0.155, respectively) but were not statistically significant.

Regarding ICU conditions, patients with delirium remained sedated and intubated for longer periods of time (6.2 vs 5 hours, *p*=0.189 and 11.5 vs 8 hours, *p*=0.001, respectively).

In terms of total ICU LOS, patients with delirium stayed in the unit for a longer period, and this was statistically significant (45.5 vs 26 hours, *p*\<0.001).

In terms of in-hospital LOS, the difference was not clinically significant, but it was found to be statistically significant; patients with delirium were hospitalized for 7.5 days, while patients without delirium stayed for 7 days (*p*=0.028).

Our intention was to emphasize on the importance of certain biomarkers in order to use them in everyday regular assessment for early delirium prognosis.

In that sense, urea and creatinine levels were found to be statistically significant on the day of the operation (patients with and without delirium: 49.5 vs 41, *p*=0.025 and 1.1 vs 1, *p*=0.018, respectively); an increase in creatinine levels was also found to be statistically significant on the first and second postoperative days (1st and 2nd postoperative day, 1.3 vs 1, *p*=0.006 and 1.3 vs 1, *p*=0.026), and we also found urea levels on the second day to be significantly elevated (40 vs 52.5, *p*=0.016).

In [Table 6](#t6-por-9-011){ref-type="table"}, we present a full view of the bivariate associations between perioperative blood results and the outcome of delirium in the study.

Looking into blood results on the operation day, neutrophil-to-lymphocyte ratio (NL ratio) was found with a *p*-value =0.061 (mean 4.6 vs 3.1), on the 1st day was not significant (mean 23.2 vs 15.2, *p*=0.166) but on the second postoperative day it was recorded as statistically significant (patients with delirium vs non delirium 18.1 vs 10.8, *p*=0.001).

We also noticed that hematocrit, Hb, and platelets for both the postoperative days of the study were correlated with delirium development.

As for clotting blood results, prolonged prothrombin time (PT) and International Normalized Ratio (INR) on the operation day were correlated with delirium (*p*\<0.001).

Finally, sodium levels were also found to present a level of statistical significance for both days (*p*-value =0.039 and *p*-value =0.033, respectively), so this could be correlated with the presence of delirium.

By using multiple logistic regressions, as shown in [Table 7](#t7-por-9-011){ref-type="table"}, we reached the conclusion that the patients who stayed longer in ICU were more susceptible to develop delirium (odds ratio 1.043 and *p*=0.011).

In addition, patients who underwent AVR + MVR ± CABG were prone to develop delirium more frequently compared to patients who did not have that type of operation (odds ratio 12.157, *p*\<0.001).

Moreover, the patients who had increased NL ratio levels on the second postoperative day had a higher chance of delirium (*p*=0.026).

Discussion
==========

In general, delirium is well noted as a quite common complication in cardiac surgical patients. Li et al[@b9-por-9-011] and Bakker et al,[@b10-por-9-011] among others, have mentioned that there has been documented a wide variety of cases with patients in delirium (10%--73%) postoperatively and large discrepancies have been recorded in documentation, data collection, and etiology regarding the "state of delirium" in the relevant published studies and papers.

In addition, it is well understood that delirium is a challenging clinical condition that becomes costly and affects health services and their staff in many aspects, as stated in the paper by Weinrebe et al[@b11-por-9-011] and Lee and Kim.[@b12-por-9-011]

Franco et al[@b13-por-9-011] and Weinrebe et al[@b11-por-9-011] also state, in their economic evaluation, that the level of provided health services consists of nursing and medical workload point of view, and financial resources' point of view as well.

Androsova et al[@b14-por-9-011] and Rudolph et al[@b15-por-9-011] make a remarkable point regarding systemic inflammatory response as a major clinical condition postoperatively, which potentially might affect the brain as well.

There needs to be a clear distinction between long-term delirium in critical care patients and short-term postoperative delirium in cardiac patients.

In recent years, it has been well established in literature that 3 distinct types of delirium exist: the hypoactive subtype, the hyperactive subtype, and the mixed motor subtype. It has also been well recognized that the hypoactive form of delirium is the one most susceptible to deterioration in patient condition.[@b27-por-9-011],[@b28-por-9-011] Arend and Christensen[@b5-por-9-011] and Meagher[@b3-por-9-011] and Stransky et al[@b4-por-9-011] in their studies show that a hypoactive patient with delirium is not easily recognized since onset; moreover, complications and side effects may have already taken place, thus directing the patient to a major condition well known as that of a "very sick patient".

Our intention was to emphasize on the importance of certain biomarkers in order to use them in the everyday routine assessment for early delirium prognosis.

This is why we exclusively investigated these biomarkers postoperatively as these could be easily measured and, above all, could render results at a low cost and much more quickly, with no extra cost apart from the everyday routine blood tests.

In that sense, we conducted a bivariate analysis between perioperative patients' characteristics and the occurrence of delirium.

A multiple logistic regression was conducted therefore, with delirium appearance as a dependent covariate. The variables that were introduced in the logistic regression model were the result of the bivariate analysis that preceded the multivariate analysis; the variables that were introduced in the model were those that showed a statistically significant relationship at the level of 0.05 (*p*\<0.05) with the dependent variable (occurrence of delirium). It is well known that the development of delirium in postsurgical patients is a multi-factorial phenomenon. The collection of the added required sample constituted a time-consuming and costly process, and it was not possible to include in the model fewer independent variables nor collect a larger sample during the period of the study.

In terms of perioperative predictors, Norkiene et al[@b2-por-9-011] in 2007 indicated the significance of specific factors which contribute to the appearance of delirium, such as prolonged sedation time, prolonged mechanical ventilation time, and prolonged length of ICU stay.

Our results, as demonstrated in [Tables 4](#t4-por-9-011){ref-type="table"} and [5](#t5-por-9-011){ref-type="table"}, also show that patients with prolonged ICU and in-hospital LOS developed delirium more frequently compared to patients with shorter LOS.

Norkiene et al[@b2-por-9-011] and Zhang et al[@b16-por-9-011] stated in their studies that patients with prolonged LOS were prone to developing delirium more frequently, and this finding was similar to our study.

Moreover, as presented in [Tables 4](#t4-por-9-011){ref-type="table"} and [5](#t5-por-9-011){ref-type="table"}, we also noticed that older age, elevated EuroSCORE II, prolonged LOS with endotracheal tube, and prolonged ICU LOS were found to be statistically and clinically significant and were also consistent with similar findings in studies by Shadvar et al[@b17-por-9-011] and Bakker et al.[@b10-por-9-011]

Total sedation time was also found prolonged in patients with delirium compared to patients with no delirium but was not statistically significant (6.2 vs 5.0, *p*=0.189).

CPB and ischemia time, as shown in [Tables 4](#t4-por-9-011){ref-type="table"} and [5](#t5-por-9-011){ref-type="table"}, were significantly prolonged but not statistically associated with delirium, whereas these findings were found increased in the study of Li et al.[@b9-por-9-011]

We also noticed, as seen in [Table 3](#t3-por-9-011){ref-type="table"}, that 13 patients out of 179 had a blood transfusion, but this was not correlated with delirium significantly (*p*=0.157). On the other hand, regarding the everyday routine blood results, as shown in [Table 6](#t6-por-9-011){ref-type="table"}, changes in postoperative hematocrit, Hb, and platelet numbers seem to raise the alarm for delirium development. A similar point about low Hb and anemia is also made in Norkiene et al's[@b2-por-9-011] study.

In terms of emphasizing the results of certain biomarker tests, Sunbul et al[@b18-por-9-011] remind us that neutrophils and leukocytes are of outmost importance for the development of inflammation, and we also have to bear in mind that Giakoumidakis et al[@b19-por-9-011] and Tan et al,[@b20-por-9-011] among others, have recently investigated NL ratio as a potential biomarker for systemic inflammatory response syndrome in cardiac patients.

We also have to mention that in Egberts' and Mattace-Raso's study[@b21-por-9-011] in acutely ill hospitalized patients, higher NL ratio in patients with delirium was found.

Moreover, we noticed that Kulaksizoglu and Kulaksizoglu[@b22-por-9-011] in their study investigated the correlation of oxidative stress and inflammation with elevated NL ratio in patients with schizophrenia.

Given all these facts and given that the severity of depression has been associated with NL ratio,[@b20-por-9-011] we hypothesized that since NL ratio was "responsible" for systemic inflammatory response syndrome and depression, we could try to investigate if there existed some sort of correlation of this biomarker with delirium as well.

In our study we also noticed that, looking into the blood results given in [Table 6](#t6-por-9-011){ref-type="table"}, NL ratio on the operation day had a *p*-value =0.061 (mean 4.6 vs 3.1), on the 1st day it was not significant (mean 23.2 vs 15.2, *p*=0.166) but on the second postoperative day it was recorded as statistically significant (patients with delirium vs without delirium 18.1 vs 10.8, *p*=0.001).

Multiple regression analysis, as presented in [Table 7](#t7-por-9-011){ref-type="table"}, revealed that patients with elevated NL ratio on the second postoperative day were more susceptible to develop delirium compared to patients with a lower NL ratio, and the *p*-value was measured as 0.026.

It was also observed that patients undergoing more complicated intraoperative procedures (2-valve replacement) had a higher chance of delirium, as in Norkiene et al's[@b2-por-9-011] study.

Urea and creatinine levels, as presented in [Tables 5](#t5-por-9-011){ref-type="table"} and [6](#t6-por-9-011){ref-type="table"}, were also found to be increased as there were cases with deteriorated preoperative renal function.

Tsuruta and Oda[@b25-por-9-011] has indicated the predictive role of certain biomarkers such as IL-6 and TNF on the increased risk of delirium development. In several studies, procalcitonine and C-reactive protein levels have also been found to be increased, indicating the association between the onset of delirium and increased levels of these biomarkers both in infectious and noninfectious conditions, as demonstrated by van den Boogaard et al[@b23-por-9-011] and Zhang et al.[@b16-por-9-011]

In our study, we did not find any statistical significance correlating CRP levels and delirium, and the explanation could be that we had a relatively small sample of patients. We also did not manage to measure procalcitonine levels, as we based our results on everyday routine blood tests only; this is something that limited the spectrum of findings in our study.

Unlike other studies, we did not find albumin levels to be statistically significant, in contrast to what has been demonstrated in Rudolph et al's[@b24-por-9-011] study. The most probable answer for this might be the fact that we had a rather small number of patients with delirium who were documented and analyzed.

Study limitations
=================

Our study had some clinical limitations. It was conducted in a single hospital, and only a small sample of population (179 patients) was investigated. The study was also based on our own resources with no further funding.

As a result, we used the everyday, routine blood tests in order to carry out our research and extract our conclusions without measuring any other specified biomarkers.

The need for research on this topic on a larger scale is obvious. Such research should be based on multicenter data collection. Prospective studies with a much greater sample size would be needed in order to determine the causality of certain risk factors for delirium.

Conclusion
==========

We feel confident in declaring that, for the most part, patients who are older, have an extended intubation period, and a prolonged ICU and in-hospital LOS are much more vulnerable to developing delirium in the ICU post cardiac surgery.

In terms of identifying certain biomarkers for early recognition of delirium, the increased NL ratio on the second postoperative day seemed to be a contributing factor to developing delirium in the ICU.

Moreover, changes in the postoperative hematocrit, Hb, and platelets are correlated with delirium development as they affect patients' general condition of health.

In addition, increased perioperative urea, creatinine, and sodium levels in those cases which highlighted the imminent appearance of delirium reflect the necessity to focus on these patients before they deteriorate and develop delirium, resulting in a prolonged hospitalization in the CICU.

Our intention to build a diagnostic tool for delirium (which would consist of RASS and CAM-ICU score, accompanied by certain biomarker results) in order to discern in a timely manner which of the cardiac patients are prone to developing delirium is at its initial steps yet, and still many initiatives need to be taken. These initiatives would strengthen our efforts to implement measures for the optimal nursing and medical interventions in order to prevent delirium development in cardiac surgical patients.
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###### 

Demographic, clinical, and perioperative patients' characteristics

  Characteristics                                 Mean (± SD)
  ----------------------------------------------- --------------
  Age (years)                                     63.3 (12.7)
  BMI (kg/m^2^)                                   28.1 (5.1)
  CPB (min)                                       121.2 (42.6)
  Ischemia time during CPB (min)                  77.4 (31.5)
  ICU LOS (hours)                                 35.1 (19.8)
  ICU LOS (days)                                  1.6 (1.8)
  In-hospital LOS (days)                          7.4 (2.9)
  Total sedation time (hours)                     7.2 (8.4)
  LOS with endotracheal tube (hours)              10.7 (11.4)
  EuroSCORE II (%)                                4 (6.0)
                                                  
                                                  **n (%)**
                                                  
  Gender                                          
   Male                                           129 (72.1)
   Female                                         50 (27.9)
  Type of surgical operation                      
   CABG                                           94 (52.5)
   AVR/MVR                                        45 (25.1)
  Bentall/--ascending aorta (±arch) replacement   12 (6.7)
   AVR + MVR (±CABG)                              23 (12.8)
   ASD/VSD                                        5 (2.8)
  Transfer to HDU                                 
   Yes                                            21 (11.7)
   No                                             158 (88.3)
  Blood transfusion                               
   Yes                                            13 (7.3)
   No                                             166 (92.7)

**Abbreviations:** AVR, aortic valve replacement; BMI, body mass index; CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; HDU, high-dependency unit; ICU, intensive care unit; LOS, length of stay; MVR, mitral valve replacement.

###### 

Patient outcomes

  Outcome    N (%)
  ---------- ------------
  Delirium   
   No        159 (88.8)
   Yes       20 (11.2)

###### 

Types of surgical operation and perioperative patient characteristics and outcomes associated with delirium

  Surgical operation                                                                                Number of patients, N (%)   Outcome (delirium)                                     *p*-value             
  ------------------------------------------------------------------------------------------------- --------------------------- ------------------------------------------------------ --------------------- ----------------------------------------------------
  CABG                                                                                                                                                                                                       **0.032**[a](#tfn3-por-9-011){ref-type="table-fn"}
   No                                                                                                                           71 (44.7)                                              14 (70.0)             
   Yes                                                                                              94 (52.5)                   88 (55.3)                                              6 (30.0)              
  AVR/MVR                                                                                                                                                                                                    0.267[a](#tfn3-por-9-011){ref-type="table-fn"}
   No                                                                                                                           117 (73.6)                                             17 (85.0)             
   Yes                                                                                              45 (25.1)                   42 (26.4)                                              3 (15.0)              
  Bentall/±ascending aorta (±arch) replacement                                                                                  0.746[a](#tfn3-por-9-011){ref-type="table-fn"}                               
   No                                                                                                                           148 (93.1)                                             19 (95.0)             
   Yes                                                                                              12 (6.7)                    11 (6.9)                                               1 (5.0)               
  AVR + MVR (± CABG)                                                                                                            \<**0.001[a](#tfn3-por-9-011){ref-type="table-fn"}**                         
   No                                                                                                                           146 (91.8)                                             10 (50.0)             
   Yes                                                                                              23 (12.8)                   13 (8.2)                                               10 (50.0)             
  ASD/VSD                                                                                                                                                                                                    0.549[a](#tfn3-por-9-011){ref-type="table-fn"}
   No                                                                                                                           154 (96.9)                                             20 (100.0)            
   Yes                                                                                              5 (2.8)                     5 (3.1)                                                0 (0.0)               
  Transfer to HDU                                                                                                               0.321[c](#tfn5-por-9-011){ref-type="table-fn"}                               
   No                                                                                               158 (88.3)                  139 (87.4)                                             19 (95.0)             
   Yes                                                                                              21 (11.7)                   20 (12.6)                                              1 (5.0)               
  Blood transfusion                                                                                                             0.157[a](#tfn3-por-9-011){ref-type="table-fn"}                               
   No                                                                                               166 (92.7)                  149 (93.7)                                             17 (85.0)             
   Yes                                                                                              13 (7.3)                    10 (6.3)                                               3 (15.0)              
  EuroSCORE II[b](#tfn4-por-9-011){ref-type="table-fn"},[c](#tfn5-por-9-011){ref-type="table-fn"}   6.2 (8.9)/1.1 (13.7)        1.7 (2/6)/3.7 (5.9)                                    3.7 (5.3)/6.3 (6.6)   **0.001**[d](#tfn6-por-9-011){ref-type="table-fn"}

**Notes:** Values are presented as n (%) unless they are mentioned otherwise.

χ^2^ test,

median (interquartile range),

mean (standard deviation),

Mann--Whitney test. Bold data are statistically significant.

**Abbreviations:** ASD, atrial septal defect; AVR, aortic valve replacement; CABG, coronary artery bypass grafting; HDU, high-dependency unit; ICU, intensive care unit; MVR, mitral valve replacement; VSD, ventricular septal defect.

###### 

Bivariate associations between delirium and patient perioperative outcomes

                                                                                                                                   Mean (standard deviation)   Median (interq range)   Outcome delirium          *p*-value                 
  -------------------------------------------------------------------------------------------------------------------------------- --------------------------- ----------------------- ------------------------- ------------------------- -------------------------------------------------------
  CPB (min)                                                                                                                        121.2 (42.6)                42.6 (113.0)            118.8 (40.2)              140.2 (56.0)              0.113[a](#tfn9-por-9-011){ref-type="table-fn"}
  Ischemia time during CPB (min)                                                                                                   77.4 (31.5)                 31.5 (70.0)             75.8 (29.7)               90.1 (42.0)               0.155[a](#tfn9-por-9-011){ref-type="table-fn"}
  ICU LOS (days)[b](#tfn10-por-9-011){ref-type="table-fn"},[c](#tfn11-por-9-011){ref-type="table-fn"}                              1.6 (1.8)                   1.8 (1.0)               1.5 (0.7)/1.0 (1.0)       2.4 (1.6)/2.0 (1.8)       \<**0.001[d](#tfn12-por-9-011){ref-type="table-fn"}**
  In-hospital LOS (days)                                                                                                           7.4 (2.9)                   2.9 (7.0)               7.3 (2.7)/7.0 (2.0)       8.8 (4.6)/7.5 (3.5)       **0.028[d](#tfn12-por-9-011){ref-type="table-fn"}**
  ICU LOS (h)                                                                                                                      35.1 (19.8)                 19.8 (29.0)             32.6 (14.5)/26.0 (19.0)   55.9 (37.7)/45.5 (31.2)   \<**0.001[d](#tfn12-por-9-011){ref-type="table-fn"}**
  Total sedation time (h)[b](#tfn10-por-9-011){ref-type="table-fn"},[c](#tfn11-por-9-011){ref-type="table-fn"}                     7.2 (8.4)                   8.4 (5.0)               6.5 (5.0)/5.0 (3.0)       13.2 (20.7)/6.3 (6.6)     0.189[d](#tfn12-por-9-011){ref-type="table-fn"}
  Length of stay with endotracheal tube (h)[b](#tfn10-por-9-011){ref-type="table-fn"},[c](#tfn11-por-9-011){ref-type="table-fn"}   10.7 (11.4)                 11.4 (8.0)              9.7 (8.1)/8.0 (4.0)       19.5 (24.1)/11.5 (10.6)   **0.001[d](#tfn12-por-9-011){ref-type="table-fn"}**

**Notes:** Values are presented as mean (standard deviation) unless they are mentioned otherwise.

*t*-test,

mean (standard deviation),

median (interquartile range),

Mann--Whitney test. Bold data are statistically significant.

**Abbreviations:** CPB, cardiopulmonary bypass; ICU, intensive care unit; LOS, length of stay.

###### 

Bivariate associations between demographic and other data and delirium development

  Independent variable                                                                                Delirium              p-value               
  --------------------------------------------------------------------------------------------------- --------------------- --------------------- -------------------------------------------------------
  Age[a](#tfn14-por-9-011){ref-type="table-fn"}                                                       62.5 (12.6)           69.6 (11.9)           **0.020[b](#tfn15-por-9-011){ref-type="table-fn"}**
  Sex                                                                                                                                             0.202[c](#tfn16-por-9-011){ref-type="table-fn"}
   Male                                                                                               117 (73.6)            12 (60.0)             
   Female                                                                                             42 (26.4)             8 (40.0)              
  Weight[a](#tfn14-por-9-011){ref-type="table-fn"}                                                    81.0 (17.0)           81.4 (12.2)           0.906[b](#tfn15-por-9-011){ref-type="table-fn"}
  Height[a](#tfn14-por-9-011){ref-type="table-fn"}                                                    170.1 (8.1)           167.2 (10.4)          0.230[b](#tfn15-por-9-011){ref-type="table-fn"}
  BMI[a](#tfn14-por-9-011){ref-type="table-fn"}                                                       27.9 (5.2)            29.2 (4.2)            0.226[b](#tfn15-por-9-011){ref-type="table-fn"}
  Surgical type of operation                                                                                                                      
   CABG                                                                                                                                           **0.032**[c](#tfn16-por-9-011){ref-type="table-fn"}
    No                                                                                                71 (44.7)             14 (70.0)             
    Yes                                                                                               88 (55.3)             6 (30.0)              
  AVR/MVR                                                                                                                                         0.267[c](#tfn16-por-9-011){ref-type="table-fn"}
   No                                                                                                 117 (73.6)            17 (85.0)             
   Yes                                                                                                42 (26.4)             3 (15.0)              
  Bentall ± ascending aorta ± arch replacement                                                                                                    0.746[c](#tfn16-por-9-011){ref-type="table-fn"}
   No                                                                                                 148 (93.1)            19 (95.0)             
   Yes                                                                                                11 (6.9)              1 (5.0)               
  AVR and MVR (± CABG)                                                                                                                            \<**0.001**[c](#tfn16-por-9-011){ref-type="table-fn"}
   No                                                                                                 146 (91.8)            10 (50.0)             
   Yes                                                                                                13 (8.2)              10 (50.0)             
  ASD/VSD                                                                                                                                         0.549[c](#tfn16-por-9-011){ref-type="table-fn"}
   No                                                                                                 154 (96.9)            20 (100.0)            
   Yes                                                                                                5 (3.1)               0 (0.0)               
  Transfer to HDU                                                                                                                                 0.321[c](#tfn16-por-9-011){ref-type="table-fn"}
   No                                                                                                 139 (87.4)            19 (95.0)             
   Yes                                                                                                20 (12.6)             1 (5.0)               
  EuroSCORE II[a](#tfn14-por-9-011){ref-type="table-fn"},[d](#tfn17-por-9-011){ref-type="table-fn"}   1.7 (2.6)/3.7 (5.9)   3.7 (5.3)/6.3 (6.6)   **0.001**[e](#tfn18-por-9-011){ref-type="table-fn"}
  CPB (min)[a](#tfn14-por-9-011){ref-type="table-fn"}                                                 118.8 (40.2)          140.2 (56.0)          0.113[b](#tfn15-por-9-011){ref-type="table-fn"}
  Ischemia time during CPB (min)[a](#tfn14-por-9-011){ref-type="table-fn"}                            75.8 (29.7)           90.1 (42.0)           0.155[b](#tfn15-por-9-011){ref-type="table-fn"}
  In-hospital LOS (days)[d](#tfn17-por-9-011){ref-type="table-fn"}                                    7.0 (2.0)             7.5 (3.5)             **0.028[f](#tfn19-por-9-011){ref-type="table-fn"}**
  ICU LOS (hours)[d](#tfn17-por-9-011){ref-type="table-fn"}                                           26.0 (19.0)           45.5 (31.2)           \<**0.001**[f](#tfn19-por-9-011){ref-type="table-fn"}
  Total sedation time (hours)[d](#tfn17-por-9-011){ref-type="table-fn"}                               5.0 (3.0)             6.2 (6.6)             0.189[f](#tfn19-por-9-011){ref-type="table-fn"}
  LOS with endotracheal tube (hours)[d](#tfn17-por-9-011){ref-type="table-fn"}                        8.0 (4.0)             11.5 (10.6)           **0.001[f](#tfn19-por-9-011){ref-type="table-fn"}**
  NL ratio, 2nd postoperative day[d](#tfn17-por-9-011){ref-type="table-fn"}                           9.2 (7.3)             16.4 (17.9)           **0.001[f](#tfn19-por-9-011){ref-type="table-fn"}**
  Urea operation day[d](#tfn17-por-9-011){ref-type="table-fn"}                                        41.0 (19.0)           49.5 (29.0)           **0.025**[f](#tfn19-por-9-011){ref-type="table-fn"}
  Urea 2nd postoperative day[d](#tfn17-por-9-011){ref-type="table-fn"}                                40.0 (25.0)           52.5 (45.5)           **0.016**[f](#tfn19-por-9-011){ref-type="table-fn"}
  Creatinine operation day[d](#tfn17-por-9-011){ref-type="table-fn"}                                  1.0 (0.3)             1.1 (0.5)             **0.018**[f](#tfn19-por-9-011){ref-type="table-fn"}
  Creatinine 1st postoperative day[d](#tfn17-por-9-011){ref-type="table-fn"}                          1.0 (0.5)             1.3 (0.5)             **0.006**[f](#tfn19-por-9-011){ref-type="table-fn"}
  Creatinine 2nd postoperative day[d](#tfn17-por-9-011){ref-type="table-fn"}                          1.0 (0.5)             1.3 (0.5)             **0.026**[f](#tfn19-por-9-011){ref-type="table-fn"}
  Sodium 1st postoperative day[@b3-por-9-011]                                                         142.7 (3.6)           144.5 (3.4)           **0.039**[b](#tfn15-por-9-011){ref-type="table-fn"}
  Sodium 2nd postoperative day[a](#tfn14-por-9-011){ref-type="table-fn"}                              141.2 (3.7)           143.4 (4.0)           **0.033**[b](#tfn15-por-9-011){ref-type="table-fn"}
  PT operation day[a](#tfn14-por-9-011){ref-type="table-fn"}                                          13.1 (1.3)            14.4 (2.4)            \<**0.001**[b](#tfn15-por-9-011){ref-type="table-fn"}
  INR operation day[a](#tfn14-por-9-011){ref-type="table-fn"}                                         1.0 (0.1)             1.2 (0.2)             \<**0.001**[b](#tfn15-por-9-011){ref-type="table-fn"}

**Notes:**

Mean (standard deviation),

2-sided *t*-test,

χ^2^,

median (interquartile range),

Monte-Carlo test,

Mann--Whitney test. Bold data are statistically significant.

**Abbreviations:** ASD, atrial septal defect; AVR, aortic valve replacement; BMI, body mass index; CABG, coronary artery bypass grafting; CPB, cardiopulmonary bypass; HDU, high-dependency unit; ICU, intensive care unit; INR, International Normalized Ratio; LOS, length of stay; MVR, mitral valve replacement; NL, neutrophil-to-lymphocyte; PT, prothrombin time; VSD, ventricular septal defect.

###### 

Bivariate associations between perioperative blood results and delirium

  Characteristics                                                              Delirium                  Delirium                  *p*-value
  ---------------------------------------------------------------------------- ------------------------- ------------------------- -------------------------------------------------------
  NL ratio, operation day[a](#tfn22-por-9-011){ref-type="table-fn"}            2.2 (1.7)/3.1 (3.0)       2.9 (1.9)/4.6 (4.8)       0.061[b](#tfn23-por-9-011){ref-type="table-fn"}
  NL ratio, 1st postoperative day[a](#tfn22-por-9-011){ref-type="table-fn"}    14.0 (9.1)/15.2 (7.3)     16.0 (11.6)/23.2 (22.0)   0.166[b](#tfn23-por-9-011){ref-type="table-fn"}
  NL ratio, 2nd postoperative day[a](#tfn22-por-9-011){ref-type="table-fn"}    9.3 (7.1)/10.8 (6.8)      16.4 (17,9)/18.1 (10.4)   **0.001[b](#tfn23-por-9-011){ref-type="table-fn"}**
  Hematocrit operation day                                                     38.0 (4.8)                36.9 (4.4)                0.292[c](#tfn24-por-9-011){ref-type="table-fn"}
  Hematocrit 1st postoperative day                                             32.5 (3.9)                30.4 (3.3)                **0.013[c](#tfn24-por-9-011){ref-type="table-fn"}**
  Hematocrit 2nd postoperative day                                             30.9 (3.6)                28.7 (3.0)                **0.005[c](#tfn24-por-9-011){ref-type="table-fn"}**
  Hb operation day                                                             12.8 (1.8)                12.2 (1.6)                0.105[c](#tfn24-por-9-011){ref-type="table-fn"}
  Hb 1st postoperative day                                                     10.9 (1.4)                10.0 (1.1)                **0.004[c](#tfn24-por-9-011){ref-type="table-fn"}**
  Hb 2nd postoperative day                                                     10.3 (1.3)                9.4 (1.0)                 **0.001[c](#tfn24-por-9-011){ref-type="table-fn"}**
  Plt operation day                                                            223.6 (65.9)              215.5 (62.6)              0.588[c](#tfn24-por-9-011){ref-type="table-fn"}
  Plt 1st postoperative day                                                    188.2 (67.1)              149.9 (52.0)              **0.006[c](#tfn24-por-9-011){ref-type="table-fn"}**
  Plt 2nd postoperative day                                                    175.6 (66.9)              135.4 (54.4)              **0.005[c](#tfn24-por-9-011){ref-type="table-fn"}**
  Urea operation day[a](#tfn22-por-9-011){ref-type="table-fn"}                 41.0 (19.0)/44.8 (22.0)   49.5 (29.0)/53.9 (23.1)   **0.025[c](#tfn24-por-9-011){ref-type="table-fn"}**
  Urea 1st postoperative day[a](#tfn22-por-9-011){ref-type="table-fn"}         40.0 (23.0)/45.5 (22.3)   47.5 (35.3)/52.9 (26.1)   0.126[b](#tfn23-por-9-011){ref-type="table-fn"}
  Urea 2nd postoperative day[a](#tfn22-por-9-011){ref-type="table-fn"}         40.0 (25.0)/48.0 (26.1)   52.5 (45.5)/62.8 (30.5)   **0.016[b](#tfn23-por-9-011){ref-type="table-fn"}**
  Creatinine operation day[a](#tfn22-por-9-011){ref-type="table-fn"}           1.0 (0.3)/1.2 (1.0)       1.1 (0.6)/12 (0.4)        **0.018[b](#tfn23-por-9-011){ref-type="table-fn"}**
  Creatinine 1st postoperative day[a](#tfn22-por-9-011){ref-type="table-fn"}   10 (0.5)/1.2 (1.0)        1.3 (0.5)/1.3 (0.4)       **0.006[b](#tfn23-por-9-011){ref-type="table-fn"}**
  Creatinine 2nd postoperative day[a](#tfn22-por-9-011){ref-type="table-fn"}   1.0 (0.5)/1.2 (1.0)       1.3 (0.5)/1.3 (0.6)       **0.026[b](#tfn23-por-9-011){ref-type="table-fn"}**
  Sodium operation day                                                         140.5 (3.1)               141.3 (4.1)               0.433[c](#tfn24-por-9-011){ref-type="table-fn"}
  Sodium 1st postoperative day                                                 142.7 (36)                1445 (34)                 **0.039[c](#tfn24-por-9-011){ref-type="table-fn"}**
  Sodium 2nd postoperative day                                                 141.2 (3.7)               143.4 (4.0)               **0.033[c](#tfn24-por-9-011){ref-type="table-fn"}**
  Albumin operation day                                                        4.0 (0.6)                 3.9 (0.4)                 0.136[c](#tfn24-por-9-011){ref-type="table-fn"}
  Albumin 1st postoperative day                                                3.5 (0.4)                 3.4 (0.4)                 0.271[c](#tfn24-por-9-011){ref-type="table-fn"}
  Albumin 2nd postoperative day                                                3.5 (0.4)                 3.5 (0.4)                 0.405[c](#tfn24-por-9-011){ref-type="table-fn"}
  CRP operation day[a](#tfn22-por-9-011){ref-type="table-fn"}                  0.4 (1.3)/1.7 (3.3)       0.3 (1.6)/1.1 (1.4)       0.719[b](#tfn23-por-9-011){ref-type="table-fn"}
  CRP 1st postoperative day                                                    7.4 (7.3)/8.8 (6.6)       5.6 (6.4)/6.9 (6.0)       0.183[b](#tfn23-por-9-011){ref-type="table-fn"}
  CRP 2nd postoperative day[a](#tfn22-por-9-011){ref-type="table-fn"}          16.5 (14.1)/16.6 (8.8)    13.2 (11.4)/13.6 (7.9)    0.163[b](#tfn23-por-9-011){ref-type="table-fn"}
  PT operation day                                                             13.1 (1.3)                14.4 (2.4)                \<**0.001**[c](#tfn24-por-9-011){ref-type="table-fn"}
  PT 1st postoperative day                                                     14.1 (3.0)                14.6 (2.8)                0.448[c](#tfn24-por-9-011){ref-type="table-fn"}
  PT 2nd postoperative day                                                     14.5 (5.6)                16.3 (9.0)                0.397[c](#tfn24-por-9-011){ref-type="table-fn"}
  INR operation day                                                            1.0 (0.1)                 1.2 (0.2)                 \<**0.001[c](#tfn24-por-9-011){ref-type="table-fn"}**
  INR 1st postoperative day                                                    1.1 (0.3)                 1.2 (0.2)                 0.529[c](#tfn24-por-9-011){ref-type="table-fn"}
  INR 2nd postoperative day                                                    1.2 (0.4)                 1.3 (0.8                  0.375[c](#tfn24-por-9-011){ref-type="table-fn"}

**Notes:** Values are presented as mean (standard deviation) unless they are mentioned otherwise.

Median (interquartile range),

Mann--Whitney test,

paired *t*-test. Bold data are statistically significant.

**Abbreviations:** CRP, C-reactive protein; Hb, hemoglobin; INR, International Normalized Ratio; NL, neutrophil-to-lymphocyte; Plt, platelet; PT, prothrombin time.

###### 

Multivariable logistic regression with delirium as dependent variable

                                    Odds ratio   95% confidence interval   *p*-value
  --------------------------------- ------------ ------------------------- -------------
  ICU LOS (hours)                   1.043        1.010--1.078              **0.011**
  NL ratio, 2nd postoperative day   1.077        1.009--1.151              **0.026**
  AVR + MVR (± CABG)                12.157       3.410--43.338             \<**0.001**

**Note:** Bold data are statistically significant.

**Abbreviations:** AVR, aortic valve replacement; CABG, coronary artery bypass grafting; ICU, intensive care unit; LOS, length of stay; MVR, mitral valve replacement; NL, neutrophil-to-lymphocyte.
